ARTICLE | Clinical News
BTI-320: Phase IIb data
November 24, 2014 8:00 AM UTC
Top-line data from the double-blind, placebo-controlled, 3-way crossover, U.S. Phase IIb SD-002 trial in 23 Type II diabetics on a stable dose of daily metformin showed that 8 patients responded to BT...